ARTV
Price
$4.00
Change
+$0.01 (+0.25%)
Updated
Feb 13 closing price
Capitalization
98.18M
44 days until earnings call
Intraday BUY SELL Signals
CUE
Price
$0.31
Change
+$0.01 (+3.33%)
Updated
Feb 13 closing price
Capitalization
28.11M
38 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARTV vs CUE

Header iconARTV vs CUE Comparison
Open Charts ARTV vs CUEBanner chart's image
Artiva Biotherapeutics
Price$4.00
Change+$0.01 (+0.25%)
Volume$39.96K
Capitalization98.18M
Cue Biopharma
Price$0.31
Change+$0.01 (+3.33%)
Volume$352.04K
Capitalization28.11M
ARTV vs CUE Comparison Chart in %
ARTV
Daily Signal:
Gain/Loss:
CUE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ARTV vs. CUE commentary
Feb 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTV is a Hold and CUE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 15, 2026
Stock price -- (ARTV: $4.00 vs. CUE: $0.31)
Brand notoriety: ARTV and CUE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTV: 3% vs. CUE: 23%
Market capitalization -- ARTV: $98.18M vs. CUE: $28.11M
ARTV [@Biotechnology] is valued at $98.18M. CUE’s [@Biotechnology] market capitalization is $28.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTV’s FA Score shows that 1 FA rating(s) are green whileCUE’s FA Score has 1 green FA rating(s).

  • ARTV’s FA Score: 1 green, 4 red.
  • CUE’s FA Score: 1 green, 4 red.
According to our system of comparison, ARTV is a better buy in the long-term than CUE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTV’s TA Score shows that 4 TA indicator(s) are bullish while CUE’s TA Score has 3 bullish TA indicator(s).

  • ARTV’s TA Score: 4 bullish, 5 bearish.
  • CUE’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, CUE is a better buy in the short-term than ARTV.

Price Growth

ARTV (@Biotechnology) experienced а -0.74% price change this week, while CUE (@Biotechnology) price change was -4.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.41%. For the same industry, the average monthly price growth was -4.89%, and the average quarterly price growth was +22.89%.

Reported Earning Dates

ARTV is expected to report earnings on Mar 30, 2026.

CUE is expected to report earnings on Mar 24, 2026.

Industries' Descriptions

@Biotechnology (+2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARTV($98.2M) has a higher market cap than CUE($28.1M). CUE YTD gains are higher at: 0.393 vs. ARTV (-6.760). CUE has higher annual earnings (EBITDA): -35.19M vs. ARTV (-83.6M). ARTV has more cash in the bank: 123M vs. CUE (18.7M). CUE has less debt than ARTV: CUE (6.17M) vs ARTV (11.7M). CUE has higher revenues than ARTV: CUE (7.1M) vs ARTV (0).
ARTVCUEARTV / CUE
Capitalization98.2M28.1M349%
EBITDA-83.6M-35.19M238%
Gain YTD-6.7600.393-1,720%
P/E RatioN/AN/A-
Revenue07.1M-
Total Cash123M18.7M658%
Total Debt11.7M6.17M190%
FUNDAMENTALS RATINGS
CUE: Fundamental Ratings
CUE
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
17

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARTVCUE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 10 days ago
84%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
70%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ARTV
Daily Signal:
Gain/Loss:
CUE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSRM28.112.18
+8.41%
SSR Mining
NPKI14.440.49
+3.51%
NPK International Inc
SO94.952.39
+2.58%
Southern Company (The)
RCKY33.110.14
+0.42%
Rocky Brands
ZBAO0.81-0.05
-5.79%
Zhibao Technology

ARTV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTV has been closely correlated with QNCX. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARTV jumps, then QNCX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTV
1D Price
Change %
ARTV100%
+0.25%
QNCX - ARTV
94%
Closely correlated
-11.31%
MREO - ARTV
89%
Closely correlated
-4.32%
TPST - ARTV
89%
Closely correlated
+2.16%
CALC - ARTV
89%
Closely correlated
-6.41%
BDRX - ARTV
82%
Closely correlated
-0.92%
More

CUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, CUE has been closely correlated with ARTV. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CUE jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CUE
1D Price
Change %
CUE100%
+2.20%
ARTV - CUE
73%
Closely correlated
+0.25%
VTGN - CUE
73%
Closely correlated
-7.23%
TPST - CUE
72%
Closely correlated
+2.16%
MREO - CUE
70%
Closely correlated
-4.32%
QNCX - CUE
69%
Closely correlated
-11.31%
More